Natco Pharma
Navigation
  • Home
  • Our Business
  • About
    • Mission & Heritage
    • Values
    • Management
    • Facilities
    • News & Announcements
  • Innovation
    • Analytical
    • Generic Research
    • Intellectual Property
    • New Drug Discovery
    • Opportunities
  • Markets
    • India
    • International
  • Investors
    • Financials
      • financials
      • Subsidiary Accounts
    • Share Monitor
    • Shareholder Information
      • Shareholding Pattern
      • Investor Service Request Form
      • Investor Presentation
      • Statutory Communications
      • Scheme of Amalgamation
      • Unclaimed Dividend
      • Investors Education Protection Fund (IEPF)
      • Buy back
        • Buy back 2018
        • Buy back 2023
      • PAPER ADVERTISEMENTS
      • Board Meeting Intimations
      • ANNUAL SECRETARIAL COMPLIANCE CERTIFICATE
      • CREDIT RATINGS
    • Annual Reports
      • Annual Return
      • AGM
      • Impact Assessment Report
    • Corporate Governance & Policies
    • Corporate Governance Certificate
    • IR AND SHAREHOLDER CONTACTS
      • INVESTOR RELATIONS
      • FOR GRIEVANCE REDRESSAL
    • QIP 2017
  • People
    • Meet Our People
    • Careers
  • Responsibility
    • CSR Policy
    • Environment, Health & Safety
      • Attivaram
      • Chemical unit-Mekaguda
      • Chemical Unit-Chennai
    • Certification & Awards
    • Natco Trust
    • Business Responsibility Policies
    • Sustainability Report
    • ESG PROFILE
  • Contact
    • Locations
    • Contact us
Navigation